AUS
NZ
UK
CA
USA
IND
Health
NanoViricides Partners with TheraCour for Antiviral Development
September 26, 2024 12:42 PM PDT| By Team Kalkine MediaHighlights,NanoViricides has signed a Memorandum of Understanding with TheraCour Pharma, granting it first refusal rights on all antiviral drug developments, enhancing access to essential intellectual property.,The collaboration supports the advancem...
Why Nevro Stands Out as a Strong Growth Candidate
September 26, 2024 12:41 PM PDT| By Team Kalkine MediaHeadlines,Nevro is positioned for growth due to advancements in its Senza product and an expanding product portfolio.,Ongoing research and development efforts are expected to drive future performance.,The company has consistently outperformed earning...
Emergent Bio Soars Following U.S. Government Order for Smallpox Therapy
September 26, 2024 12:15 PM PDT| By Team Kalkine MediaHeadlines,Emergent Bio's stock sees an uptick due to recent government contracts.,The order for smallpox therapy highlights the increasing demand for biodefense products.,Investors are keenly watching the company’s growth in the public health sector....
CASI Pharmaceuticals Faces Recent Decline After Robust Year
September 26, 2024 12:01 PM PDT| By Team Kalkine MediaHighlights,CASI Pharmaceuticals has faced a significant share price decline this week, yet it has achieved impressive annual returns, indicating ongoing shareholder optimism.,The company has not been profitable recently and experienced a notable reve...
Belite Bio Navigates Cash Challenges in Quest for Biotech Breakthrough
September 26, 2024 09:48 AM PDT| By Team Kalkine MediaHighlights,Southwest Airlines' shares surged after updating its third-quarter revenue forecast in the airline sector.,The airline introduced a three-year plan including assigned seating and premium options to enhance services.,Expanding partnerships...
Patterson Companies Expands Animal Health Division with Strategic Acquisitions in the U.K. and U.S.
September 26, 2024 04:04 AM PDT| By Team Kalkine MediaPatterson Companies, Inc. (Nasdaq:PDCO), a prominent distribution company in the dental and animal health sectors, has announced significant strides in its Animal Health business through two separate acquisition agreements. The company will acquire I...
.jpg)
Enanta Pharmaceuticals Reports Promising Phase 2a Results for EDP-323 in RSV Treatment
September 26, 2024 04:00 AM PDT| By Team Kalkine MediaEnanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company focused on developing innovative small molecule drugs for virology and immunology, has announced encouraging topline results from a Phase 2a human challenge study of...
Eli Lilly Rises Toward Market Milestone with Innovative Drug Advances
September 25, 2024 01:37 PM PDT| By Team Kalkine MediaHighligths,Eli Lilly's shares are nearing all-time highs, driven by recent FDA approvals and strong revenue growth from its GLP-1 drugs, which have significantly boosted sales.,The company has raised its revenue guidance and continues to prioritize s...
Pfizer Shares Experience Minor Decline
September 25, 2024 12:54 PM PDT| By Team Kalkine MediaHeadlines,Pfizer's stock price decreased by 0.8% during Wednesday's trading session.,Shares traded at a low of $29.23 before closing at $29.26, down from the previous close of $29.50.,Trading volume saw a significant drop, with approximately 7.9 mill...
Kenvue Stock Analysis and Market Updates
September 25, 2024 11:02 AM PDT| By Team Kalkine MediaHeadlines,Kenvue is enhancing its product line with sustainable and innovative solutions.,Strategic partnerships are driving growth and market leadership.,A strong focus on consumer health trends positions Kenvue favorably in the industry.,Kenvue,(NY...
Theralase Technologies Pioneers Light-Activated Cancer Therapies
September 25, 2024 07:46 AM PDT| By Team Kalkine MediaHighlights,Successful Fundraising,: Theralase Technologies has raised $544,000 through a non-brokered private placement, which will support its clinical trials and research initiatives.,Promising Drug Developments,: The company’s lead drug formulatio...
_09_25_2024_14_24_01_892990.jpg)
Shield Therapeutics Shares Rise 8% Following Phase III Trial Success
September 25, 2024 07:20 AM PDT| By Team Kalkine MediaHighlights,Positive Phase III Trial Results: Shield Therapeutics announced successful phase III trial results for its iron deficiency treatment, Accrufer, demonstrating significant efficacy in pediatric patients.,Efficacy in Children: The oral medica...
Lifeward Ltd. (Nasdaq: LFWD) Expands Offerings in Germany with AlterG Product Line
September 24, 2024 11:15 PM PDT| By Team Kalkine MediaLifeward Ltd. (Nasdaq:LFWD), a leading innovator in rehabilitation and recovery solutions, has announced an exciting expansion of its product offerings in Germany. Effective immediately, Lifeward will begin selling the AlterG family of products throu...
Regeneron Faces Setback After Court Ruling on Eylea Biosimilar
September 24, 2024 12:14 PM PDT| By Team Kalkine MediaHeadlines,Regeneron Pharmaceuticals' shares fell by 4.63% following a court ruling.,The decision involved a legal dispute with Amgen regarding the biosimilar of Eylea.,The outcome may influence Regeneron's market position and future developments.,Reg...
Takeda Secures Approval for FRUZAQLA® in Japan, Offering New Hope for Metastatic Colorectal Cancer Patients
September 24, 2024 02:05 AM PDT| By Team Kalkine MediaHUTCHMED (China) Limited (“HUTCHMED”) has announced a significant milestone in cancer treatment with its partner Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) receiving approval from the Japanese Ministry of Health, Labour and Welfare (...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) Welcomes New CEO Catherine Owen Adams
September 24, 2024 01:19 AM PDT| By Team Kalkine MediaAcadia Pharmaceuticals Inc. has announced a significant leadership change with Catherine Owen Adams stepping in as the new Chief Executive Officer (CEO), succeeding Steve Davis. Adams also joins the Acadia Board of Directors, marking a new chapter fo...
DBV Technologies (Nasdaq: DBVT) Completes Patient Screening for VITESSE Phase 3 Trial
September 24, 2024 01:10 AM PDT| By Team Kalkine MediaDBV Technologies (Nasdaq:DBVT), a clinical-stage biopharmaceutical company, has announced a major advancement in its research efforts against peanut allergies. The company has completed patient screening for its Phase 3 trial, known as VITESSE (Viask...
Scancell Holdings Unveils Strategic Roadmap for Next 18 Months
September 24, 2024 12:26 AM PDT| By Team Kalkine MediaScancell Holdings PLC, a company specializing in,Healthcare Sector,, has announced its strategic roadmap for the upcoming 18 months, building on substantial clinical advancements achieved thus far. This comprehensive plan outlines key milestones aime...
VSee Health Reports Growth Post-Merger and Expansion of Telehealth Services
September 23, 2024 05:39 PM PDT| By Team Kalkine MediaOverview of VSee Health, Inc. (NASDAQ: VSEE),VSee Health, Inc. (NASDAQ: VSEE), a prominent telehealth service provider, has recently disclosed its business update along with financial results for the second quarter and first half of the year ending J...
Understanding the Recent Upgrade for Applied Therapeutics (APLT)
September 23, 2024 04:16 PM PDT| By Team Kalkine MediaHeadlines,Applied Therapeutics Inc.,(NASDAQ:APLT),has received a rating upgrade reflecting positive changes in earnings estimates.,The upgrade is based on an upward trend in earnings, a significant factor influencing stock performance.,The Zacks rati...
